Multiplex Assays Market Report, published by Allied Market Research, forecasts that the global market was valued at $3,470 million in 2015 and is expected to garner $5,720 million by 2022, registering a CAGR of 7.4% during the forecast period 2016-2022.
2. Multiplex Assays Market: Future and Growth
• The global market was valued at $3,470 million in 2015 and is
expected to garner $5,720 million by 2022
• Registering a CAGR of 7.4% during the forecast period 2016-2022
• The protein-based multiplex assays segment held over two-thirds
share of the total market in 2015
• The multiplex assays reagents & consumable market held the
highest share of three-fourths in 2015
• Pharmaceuticals & biotechnological companies in end users held
the highest market share of multiplex assays market in 2015
3. Multiplex Assays Market: Factors for Market
Growth
• Multiplex assays analyze multiple analytes at the same time
• Extract more data from a sample in less time as compared to
single-plex assays
• Increase in research & development activities for the detection
of biomarkers for various diseases & treatment options of the
diseases
• Rise in adoption of personalized medicine for increasing safety
& efficacy of therapies
• Benefits, such as lower operational cost & reduced labor
• Technological advancements
4. Multiplex Assays Market: Key Players
• The multiplex assays reagents & consumable market accounted
for the highest market share for product segment in 2015, and is
also estimated to grow at the highest CAGR of 7.7% in the
analysis period.
• By application, research and development held the highest
market share and expected to lead the market during the analysis
period.
• U.S. was the highest shareholder in the North American multiplex
assays market, accounting for six-sevenths share in 2015.
• China is expected to show the highest growth rate during the
analysis period in the Asia-Pacific multiplex assays market.
5. Multiplex Assays Market Segmentation
By Type
•Nucleic Acid-
Based Multiplex
Assays
•Protein-Based
Multiplex Assays
By Product
•Multiplex Assay
Reagents &
Consumable
• Multiplex Assay
Instruments &
Accessories
• Multiplex Assay
Software and
Services
By Technology
• Multiplex PCR
• Multiplex
Protein
Microarray
By Application
• Companion
Diagnostics
•Research &
Development
•Clinical
Diagnostics
By End User
• Hospitals
• Clinical
Laboratories
• Research
Institutes
• Pharmaceuticals
&
Biotechnological
Companies
The market is segmented into various types:
6. Multiplex Assays Market Segmentation
• Geographically, the global multiplex assays market is analyzed by
four regions, namely, North America, Europe, Asia-Pacific, and
LAMEA
• North America was the highest revenue contributor with
approximately half of the share in 2015, and is attributed to the
ample amount of expenditure in healthcare, research &
development, well-established healthcare system, and higher
demand for technically advanced devices for research work
• Asia-Pacific is anticipated to grow with the highest CAGR during
the analysis period, owing to rise in healthcare expenditure,
increase in per capita income & improved healthcare
infrastructure.
7. Multiplex Assays Market: Key Players
• Luminex Corporation
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• QIAGEN N.V.
• Becton, Dickinson and Company
• Abcam PLC.
• Seegene Inc.
• Meso Scale Diagnostics, LLC. and
• Randox Laboratories Ltd.
8. Follow us on:
Summary:
Protein-based multiplex assays are expected to dominate global multiplex assays market
during the forecast period, owing to their rise in adoption to analyze unknown proteins and
their functions simultaneously and precisely
To know more about the Multiplex Assays Market, visit:
https://www.alliedmarketresearch.com/multiplex-assays-market